124 related articles for article (PubMed ID: 24618433)
1. Translational research in pancreatic adenocarcinoma.
Kaur G; Saif MW
JOP; 2014 Mar; 15(2):121-3. PubMed ID: 24618433
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic cancer: updates on translational research and future applications.
Sarris EG; Syrigos KN; Saif MW
JOP; 2013 Mar; 14(2):145-8. PubMed ID: 23474558
[TBL] [Abstract][Full Text] [Related]
3. BRCA and pancreatic cancer: selection of chemotherapy.
Kim R; Byer J; Saif MW
JOP; 2012 Mar; 13(2):180-1. PubMed ID: 22406596
[TBL] [Abstract][Full Text] [Related]
4. Translational research. New findings and potential future applications in pancreatic adenocarcinoma.
Strimpakos AS; Syrigos KN; Saif MW
JOP; 2012 Mar; 13(2):177-9. PubMed ID: 22406595
[TBL] [Abstract][Full Text] [Related]
5. Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma.
Holter S; Borgida A; Dodd A; Grant R; Semotiuk K; Hedley D; Dhani N; Narod S; Akbari M; Moore M; Gallinger S
J Clin Oncol; 2015 Oct; 33(28):3124-9. PubMed ID: 25940717
[TBL] [Abstract][Full Text] [Related]
6. Translational research in pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
Strimpakos AS; Syrigos KN; Saif MW
JOP; 2010 Mar; 11(2):124-7. PubMed ID: 20208318
[TBL] [Abstract][Full Text] [Related]
7. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
8. BRCA and pancreatic cancer.
Brennan GT; Relias V; Saif MW
JOP; 2013 Jul; 14(4):325-8. PubMed ID: 23846919
[TBL] [Abstract][Full Text] [Related]
9. Identification of prognostic and predictive markers in pancreatic adenocarcinoma. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
Russo SM; Ove R; Saif MW
JOP; 2011 Mar; 12(2):92-5. PubMed ID: 21386628
[TBL] [Abstract][Full Text] [Related]
10. BRCA-associated pancreatic cancer: the evolving management.
Leung K; Saif MW
JOP; 2013 Mar; 14(2):149-51. PubMed ID: 23474559
[TBL] [Abstract][Full Text] [Related]
11. Association of BRCA Mutations and Pancreatic Cancer: Review of Literature and Meta-analysis.
Chandan S; Deliwala SS; Facciorusso A; Mohan BP; Ramai D; Kochhar GS
Pancreas; 2022 Jan; 51(1):e8-e10. PubMed ID: 35195609
[No Abstract] [Full Text] [Related]
12. Translational research in pancreatic cancer. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
Strimpakos AS; Syrigos KN; Saif MW
JOP; 2011 Mar; 12(2):120-2. PubMed ID: 21386635
[TBL] [Abstract][Full Text] [Related]
13. BRCAPRO 6.0 Model Validation in Male Patients Presenting for BRCA Testing.
Mitri ZI; Jackson M; Garby C; Song J; Giordano SH; Hortobágyi GN; Singletary CN; Hashmi SS; Arun BK; Litton JK
Oncologist; 2015 Jun; 20(6):593-7. PubMed ID: 25948675
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic cancer: BRCA mutation and personalized treatment.
Luo G; Lu Y; Jin K; Cheng H; Guo M; Liu Z; Long J; Liu C; Ni Q; Yu X
Expert Rev Anticancer Ther; 2015; 15(10):1223-31. PubMed ID: 26402249
[TBL] [Abstract][Full Text] [Related]
15. The relevance of BRCA genetics to prostate cancer pathogenesis and treatment.
Sundararajan S; Ahmed A; Goodman OB
Clin Adv Hematol Oncol; 2011 Oct; 9(10):748-55. PubMed ID: 22252577
[TBL] [Abstract][Full Text] [Related]
16. Predominant Ashkenazi BRCA1/2 mutations in families with pancreatic cancer.
Dagan E
Genet Test; 2008 Jun; 12(2):267-71. PubMed ID: 18439109
[TBL] [Abstract][Full Text] [Related]
17. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.
Lal G; Liu G; Schmocker B; Kaurah P; Ozcelik H; Narod SA; Redston M; Gallinger S
Cancer Res; 2000 Jan; 60(2):409-16. PubMed ID: 10667595
[TBL] [Abstract][Full Text] [Related]
18. Assessing the Significance of BRCA1 and BRCA2 Mutations in Pancreatic Cancer.
Carnevale J; Ashworth A
J Clin Oncol; 2015 Oct; 33(28):3080-1. PubMed ID: 25987697
[No Abstract] [Full Text] [Related]
19. BRCA1 missense polymorphisms are associated with poor prognosis of pancreatic cancer patients in a Chinese population.
Zhu Y; Zhai K; Ke J; Li J; Gong Y; Yang Y; Tian J; Zhang Y; Zou D; Peng X; Gong J; Zhong R; Huang K; Chang J; Miao X
Oncotarget; 2017 May; 8(22):36033-36039. PubMed ID: 28415599
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of K-ras, BRCA1/2, CHEK2 mutations and microsatellite markers (loss of heterozygosity at 9p, 17p and 18q) in sporadic pancreas adenocarcinomas].
Amosenko FA; Kazubskaia TP; Gromyko OE; Matveeva TI; Korchagina EL; Nasedkina TV; Gar'kavtseva RF; Kalinin VN
Mol Biol (Mosk); 2009; 43(3):414-21. PubMed ID: 19548527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
